xylasol 100 mg/ml inj. opl. i.m./i.v. flac.
cp-pharma handelsgesellschaft - xylazinehydrochloride 116.55 mg/ml - eq. xylazine 100 mg/ml - oplossing voor injectie - 100 mg/ml - xylazinehydrochloride 116.55 mg/ml - xylazine - rund; paard
mircera
roche registration gmbh - methoxy polyethyleen glycol-epoetin beta - anemia; kidney failure, chronic - antianemische preparaten - treatment of symptomatic anaemia associated with chronic kidney disease (ckd) in adult patients (see section 5. treatment of symptomatic anaemia associated with chronic kidney disease (ckd) in paediatric patients from 3 months to less than 18 years of age who are converting from another erythropoiesis stimulating agent (esa) after their haemoglobin level was stabilised with the previous esa (see section 5.
venoruton forte 500 mg tablet
impexeco - hydroxyethyl-o-(bèta-)-rutoside - tablet - 500 mg - hydroxyethyl-o-(bèta-)-rutoside 500 mg - troxerutin, combinations
voluven 10 % inf. opl. i.v.
fresenius kabi sa-nv - natriumchloride 4,5 g/500 ml; hydroxyethylzetmeel 50 g/500 ml - oplossing voor infusie - 10 % (100 mg/ml) - natriumchloride 9 mg/ml; hydroxyethylzetmeel 100 mg/ml - hydroxyethylstarch
venoruton forte 500 mg tablet
orifarm - hydroxyethyl-o-(bèta-)-rutoside - tablet - 500 mg - hydroxyethyl-o-(bèta-)-rutoside 500 mg - troxerutin, combinations
esomeprazol renantos 20 mg, maagsapresistente tabletten
renantos pharmavertriebsgesellschaft mbh - esomeprazol magnesium 2-water samenstelling overeenkomend met ; esomeprazol - maagsapresistente tablet - cellulose, microkristallijn (e 460) ; copolymeer van ethylacrylaat-methacrylzuur (1:1) ; glycerolmonostearaat 40-55 (e 471) ; hypromellose (e 464) ; ijzeroxide geel (e 172) ; ijzeroxide rood (e 172) ; macrogol 4000 ; mannitol (d-) (e 421) ; maÏszetmeel ; natriumstearylfumaraat ; paraffine, hard (e 905) ; polysorbaat 80 (e 433) ; povidon k 90 (e 1201) ; saccharose ; sugar spheres ; talk (e 553 b) ; titaandioxide (e 171) ; triethylcitraat (e 1505), - esomeprazole
esomeprazol renantos 40 mg, maagsapresistente tabletten
renantos pharmavertriebsgesellschaft mbh - esomeprazol magnesium 2-water samenstelling overeenkomend met ; esomeprazol - maagsapresistente tablet - cellulose, microkristallijn (e 460) ; copolymeer van ethylacrylaat-methacrylzuur (1:1) ; glycerolmonostearaat 40-55 (e 471) ; hypromellose (e 464) ; ijzeroxide geel (e 172) ; ijzeroxide rood (e 172) ; macrogol 4000 ; mannitol (d-) (e 421) ; maÏszetmeel ; natriumstearylfumaraat ; paraffine, hard (e 905) ; polysorbaat 80 (e 433) ; povidon k 90 (e 1201) ; saccharose ; sugar spheres ; talk (e 553 b) ; titaandioxide (e 171) ; triethylcitraat (e 1505), - esomeprazole
losartankalium aurobindo 100 mg, filmomhulde tabletten
aurobindo pharma b.v. - losartan kalium samenstelling overeenkomend met; losartan; - filmomhulde tablet - losartan
losartankalium aurobindo 50 mg, filmomhulde tabletten
aurobindo pharma b.v. - losartan kalium samenstelling overeenkomend met; losartan; - filmomhulde tablet - losartan
pelmeg
mundipharma corporation (ireland) limited - pegfilgrastim - neutropenie - immunostimulants, - te verminderen de duur van de neutropenie en de incidentie van febriele neutropenie als gevolg van chemotherapie.